Rubric Capital Management (New York)’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$3.61M Buy
2020
Q4
Sell
2020
Q3
$8.14M Sell
2020
Q2
$19.9M Buy
2020
Q1
$20.2M Buy
2019
Q4
$4.49M Buy